Strand Therapeutics
PrivateLast Round
Series B
Mar 17, 2026
Est. Valuation
$550M
Total Funding Raised
$266M
Company Overview
Strand Therapeutics is a biotechnology company that develops programmable, long-acting mRNA therapeutics designed to deliver precise, multi-functional treatments for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strand Therapeutics Comparables
Compare Strand Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kernalbio | 84% | |
| Bristol Myers Squibb | 84% | |
| Replicate Bioscience | 82% | |
Strand Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2026 | ||||
| Series B | Aug 7, 2025 | ||||
| Series A Extension | Nov 28, 2022 | ||||
| Series A | Jun 23, 2021 | ||||
| Corporate Funding | Jan 11, 2021 | ||||
Seed | Jun 4, 2019 |
Key People
Founding team and executive leadership
Strand Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| Alderline Group | Series B |
| ICONIQ Capital | Series B |
| Camford Capital | Series A |
| Playground Global | Series B, Series A Extension, Series A, Seed |
| LG Technology Ventures | Series B |
| ANRI株式会社 | Series B, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Lead program STX-001 now in Phase 1 trial for solid tumors.
- Aug 23, 2025
Dr. Jason J. Luke appointed as new Chief Medical Officer.
Strand Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Strand Therapeutics's valuation, stock price, and market status.